Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 384 articles:
HTML format
Text format



Single Articles


    January 2018
  1. PLACZEK WJ, Yanagawa H, Makita Y, Renfrow MB, et al
    Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    PLoS One. 2018;13:e0190967.
    PubMed     Text format     Abstract available


  2. OZTURK MC, Xu Q, Cinar A
    Agent-based modeling of the interaction between CD8+ T cells and Beta cells in type 1 diabetes.
    PLoS One. 2018;13:e0190349.
    PubMed     Text format     Abstract available


  3. AGAH E, Zardoui A, Saghazadeh A, Ahmadi M, et al
    Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0190252.
    PubMed     Text format     Abstract available


  4. AKERMAN L, Casas R, Ludvigsson J, Tavira B, et al
    Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
    PLoS One. 2018;13:e0191067.
    PubMed     Text format     Abstract available


  5. WANG C, Klistorner A, Ly L, Barnett MH, et al
    White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques.
    PLoS One. 2018;13:e0191131.
    PubMed     Text format     Abstract available


  6. LAVTAR P, Rudolf G, Maver A, Hodzic A, et al
    Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.
    PLoS One. 2018;13:e0190601.
    PubMed     Text format     Abstract available


  7. MEMON AB, Javed A, Caon C, Srivastawa S, et al
    Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.
    PLoS One. 2018;13:e0190425.
    PubMed     Text format     Abstract available


  8. HENSCHEL AM, Cabrera SM, Kaldunski ML, Jia S, et al
    Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and beta-cell chemokine expression associated with autoimmune diabetes susceptibility.
    PLoS One. 2018;13:e0190351.
    PubMed     Text format     Abstract available


  9. DAHDAL S, Devetzis V, Chalikias G, Tziakas D, et al
    Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
    PLoS One. 2018;13:e0188695.
    PubMed     Text format     Abstract available


  10. SHIN S, Jung CH, Choi JY, Kwon HW, et al
    Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
    PLoS One. 2018;13:e0191421.
    PubMed     Text format     Abstract available


  11. BEGGS CB, Giaquinta A, Veroux M, De Marco E, et al
    Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis.
    PLoS One. 2018;13:e0191534.
    PubMed     Text format     Abstract available


  12. BONNET-SERRANO F, Diedisheim M, Mallone R, Larger E, et al
    Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository.
    PLoS One. 2018;13:e0191528.
    PubMed     Text format     Abstract available


  13. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility.
    PLoS One. 2018;13:e0190043.
    PubMed     Text format     Abstract available


  14. HASSANI A, Corboy JR, Al-Salam S, Khan G, et al
    Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
    PLoS One. 2018;13:e0192109.
    PubMed     Text format     Abstract available


  15. LIMIRIO PHJO, da Rocha Junior HA, Morais RB, Hiraki KRN, et al
    Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats.
    PLoS One. 2018;13:e0191694.
    PubMed     Text format     Abstract available


  16. SIMEONOVIC CJ, Popp SK, Starrs LM, Brown DJ, et al
    Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.
    PLoS One. 2018;13:e0191360.
    PubMed     Text format     Abstract available


  17. CALOCER F, Dejardin O, Droulon K, Launoy G, et al
    Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.
    PLoS One. 2018;13:e0191646.
    PubMed     Text format     Abstract available


  18. MUKHOPADHYAY N, Noble JA, Govil M, Marazita ML, et al
    Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk.
    PLoS One. 2018;13:e0192696.
    PubMed     Text format     Abstract available


  19. ISLAM Z, Jahan I, Ahammad RU, Shahnaij M, et al
    FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barre syndrome.
    PLoS One. 2018;13:e0192703.
    PubMed     Text format     Abstract available


  20. DE FLON P, Soderstrom L, Laurell K, Dring A, et al
    Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.
    PLoS One. 2018;13:e0192516.
    PubMed     Text format     Abstract available


  21. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Text format     Abstract available


  22. DENNISON L, Brown M, Kirby S, Galea I, et al
    Do people with multiple sclerosis want to know their prognosis? A UK nationwide study.
    PLoS One. 2018;13:e0193407.
    PubMed     Text format     Abstract available


  23. POTTGEN J, Rose A, van de Vis W, Engelbrecht J, et al
    Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review.
    PLoS One. 2018;13:e0193381.
    PubMed     Text format     Abstract available


  24. WALLUKAT G, Pruss H, Muller J, Schimke I, et al
    Functional autoantibodies in patients with different forms of dementia.
    PLoS One. 2018;13:e0192778.
    PubMed     Text format     Abstract available


  25. RAHIMI F, Rasekh HR, Abbasian E, Peiravian F, et al
    Patient preferences for Interferon-beta in Iran: A discrete choice experiment.
    PLoS One. 2018;13:e0193090.
    PubMed     Text format     Abstract available


  26. BAGNATO F, Hametner S, Boyd E, Endmayr V, et al
    Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.
    PLoS One. 2018;13:e0193839.
    PubMed     Text format     Abstract available


  27. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Text format     Abstract available


  28. STOUSTRUP P, Iversen CK, Kristensen KD, Resnick CM, et al
    Assessment of dentofacial growth deviation in juvenile idiopathic arthritis: Reliability and validity of three-dimensional morphometric measures.
    PLoS One. 2018;13:e0194177.
    PubMed     Text format     Abstract available


  29. PARK KH, Waters P, Woodhall M, Lang B, et al
    Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    PLoS One. 2018;13:e0193723.
    PubMed     Text format     Abstract available


  30. KHAN A, Kamran S, Ponirakis G, Akhtar N, et al
    Peripheral neuropathy in patients with multiple sclerosis.
    PLoS One. 2018;13:e0193270.
    PubMed     Text format     Abstract available


  31. DRABORG AH, Rasmussen NS, Larsen JL, Jorgensen CS, et al
    Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    PLoS One. 2018;13:e0193244.
    PubMed     Text format     Abstract available


  32. GERASIMOU P, Nicolaidou V, Skordis N, Picolos M, et al
    Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.
    PLoS One. 2018;13:e0193684.
    PubMed     Text format     Abstract available


  33. CUI J, Yan W, Xu S, Wang Q, et al
    Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    PLoS One. 2018;13:e0193171.
    PubMed     Text format     Abstract available


  34. NARDIN C, Latarche C, Soudant M, Dahan C, et al
    Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.
    PLoS One. 2018;13:e0194115.
    PubMed     Text format     Abstract available


  35. HASLACHER H, Fallmann H, Waldhausl C, Hartmann E, et al
    Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report.
    PLoS One. 2018;13:e0194135.
    PubMed     Text format     Abstract available


  36. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.
    PLoS One. 2018;13:e0193728.
    PubMed     Text format     Abstract available


  37. PONSONBY AL, Pezic A, Cameron FJ, Rodda C, et al
    Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices.
    PLoS One. 2018;13:e0193992.
    PubMed     Text format     Abstract available


  38. KOZIARSKA D, Krol J, Nocon D, Kubaszewski P, et al
    Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.
    PLoS One. 2018;13:e0194117.
    PubMed     Text format     Abstract available


  39. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    PubMed     Text format     Abstract available


  40. TURTON JL, Raab R, Rooney KB
    Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review.
    PLoS One. 2018;13:e0194987.
    PubMed     Text format     Abstract available


  41. HOLM LJ, Haupt-Jorgensen M, Larsen J, Giacobini JD, et al
    L-serine supplementation lowers diabetes incidence and improves blood glucose homeostasis in NOD mice.
    PLoS One. 2018;13:e0194414.
    PubMed     Text format     Abstract available


  42. ANDROULIDAKI A, Wachsmuth L, Polykratis A, Pasparakis M, et al
    Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.
    PLoS One. 2018;13:e0194048.
    PubMed     Text format     Abstract available


  43. KODA T, Namba A, Nakatsuji Y, Niino M, et al
    Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    PLoS One. 2018;13:e0193986.
    PubMed     Text format     Abstract available


  44. GARNIER AS, Duveau A, Demiselle J, Croue A, et al
    Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    PLoS One. 2018;13:e0196101.
    PubMed     Text format     Abstract available


  45. MORILLAS-DE-LAGUNO P, Vargas-Hitos JA, Rosales-Castillo A, Saez-Uran LM, et al
    Association of objectively measured physical activity and sedentary time with arterial stiffness in women with systemic lupus erythematosus with mild disease activity.
    PLoS One. 2018;13:e0196111.
    PubMed     Text format     Abstract available


  46. KLISTORNER A, Wang C, Yiannikas C, Parratt J, et al
    Diffusivity in the core of chronic multiple sclerosis lesions.
    PLoS One. 2018;13:e0194142.
    PubMed     Text format     Abstract available


  47. FIGUEIREDO-BRAGA M, Cornaby C, Bernardes M, Figueiredo M, et al
    Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease.
    PLoS One. 2018;13:e0195579.
    PubMed     Text format     Abstract available


  48. MIZUGUCHI Y, Morimoto S, Kimura S, Takano N, et al
    Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    PLoS One. 2018;13:e0195464.
    PubMed     Text format     Abstract available


  49. NOVAKOVA L, Axelsson M, Malmestrom C, Imberg H, et al
    Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
    PLoS One. 2018;13:e0194828.
    PubMed     Text format     Abstract available


  50. MOSER O, Eckstein ML, McCarthy O, Deere R, et al
    Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes.
    PLoS One. 2018;13:e0194750.
    PubMed     Text format     Abstract available


  51. TAYLOR MEADOWS KR, Steinberg MW, Clemons B, Stokes ME, et al
    Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus.
    PLoS One. 2018;13:e0193236.
    PubMed     Text format     Abstract available


  52. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Schuster T, et al
    Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population.
    PLoS One. 2018;13:e0196244.
    PubMed     Text format     Abstract available


  53. UECHI E, Okada M, Fushimi K
    Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database.
    PLoS One. 2018;13:e0196009.
    PubMed     Text format     Abstract available


  54. ISING E, Dahlin LB, Elding Larsson H
    Impaired vibrotactile sense in children and adolescents with type 1 diabetes - Signs of peripheral neuropathy.
    PLoS One. 2018;13:e0196243.
    PubMed     Text format     Abstract available


  55. LARANJEIRA FO, de Andrade KRC, Figueiredo ACMG, Silva EN, et al
    Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0194801.
    PubMed     Text format     Abstract available


  56. HESSELS AC, Rutgers A, Sanders JSF, Stegeman CA, et al
    Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.
    PLoS One. 2018;13:e0195524.
    PubMed     Text format     Abstract available


  57. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Text format     Abstract available


  58. NWOSU BU, Zhang B, Ayyoub SS, Choi S, et al
    Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    PLoS One. 2018;13:e0196912.
    PubMed     Text format     Abstract available


  59. FERNANDEZ O, Izquierdo G, Fernandez V, Leyva L, et al
    Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
    PLoS One. 2018;13:e0195891.
    PubMed     Text format     Abstract available


  60. KRAAL LJN, Nijland ML, Germar KL, Baeten DLP, et al
    Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.
    PLoS One. 2018;13:e0197219.
    PubMed     Text format     Abstract available


  61. WITHER JE, Prokopec SD, Noamani B, Chang NH, et al
    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.
    PLoS One. 2018;13:e0196117.
    PubMed     Text format     Abstract available


  62. HANAOKA H, Iida H, Kiyokawa T, Takakuwa Y, et al
    Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
    PLoS One. 2018;13:e0196172.
    PubMed     Text format     Abstract available


  63. CECCARELLI F, Perricone C, Pirone C, Massaro L, et al
    Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
    PLoS One. 2018;13:e0196103.
    PubMed     Text format     Abstract available


  64. LIN Y, Liu L, Sheng Y, Shen C, et al
    A catalog of potential putative functional variants in psoriasis genome-wide association regions.
    PLoS One. 2018;13:e0196635.
    PubMed     Text format     Abstract available


  65. STORM FA, Nair KPS, Clarke AJ, Van der Meulen JM, et al
    Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    PLoS One. 2018;13:e0196463.
    PubMed     Text format     Abstract available


  66. DE SANTIAGO L, Sanchez-Morla E, Blanco R, Miguel JM, et al
    Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLoS One. 2018;13:e0194964.
    PubMed     Text format     Abstract available


  67. CIURLEO R, Bonanno L, De Salvo S, Romeo L, et al
    Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
    PLoS One. 2018;13:e0196006.
    PubMed     Text format     Abstract available


  68. SANCHEZ-DALMAU B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, et al
    Predictors of vision impairment in Multiple Sclerosis.
    PLoS One. 2018;13:e0195856.
    PubMed     Text format     Abstract available


  69. MASUDA K, Tanabe K, Ujike H, Hinamoto N, et al
    Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    PLoS One. 2018;13:e0195779.
    PubMed     Text format     Abstract available


  70. DESHAYES S, Aouba A, Khoy K, Mariotte D, et al
    Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis.
    PLoS One. 2018;13:e0195680.
    PubMed     Text format     Abstract available


  71. WUERFEL E, Weddige A, Hagmayer Y, Jacob R, et al
    Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    PLoS One. 2018;13:e0194873.
    PubMed     Text format     Abstract available


  72. TAHVILI S, Torngren M, Holmberg D, Leanderson T, et al
    Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
    PLoS One. 2018;13:e0196598.
    PubMed     Text format     Abstract available


  73. MIKI A, Ricordi C, Sakuma Y, Yamamoto T, et al
    Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
    PLoS One. 2018;13:e0196570.
    PubMed     Text format     Abstract available


  74. DUARTE-GARCIA A, Romero-Diaz J, Juarez S, Cicero-Casarrubias A, et al
    Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
    PLoS One. 2018;13:e0196487.
    PubMed     Text format     Abstract available


  75. SCARR D, Lovblom LE, Cardinez N, Orszag A, et al
    Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    PLoS One. 2018;13:e0196647.
    PubMed     Text format     Abstract available


  76. CHROBOK NL, Bol JGJM, Jongenelen CA, Breve JJP, et al
    Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    PLoS One. 2018;13:e0196433.
    PubMed     Text format     Abstract available


  77. PACKIALAKSHMI B, Zhou X
    Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex.
    PLoS One. 2018;13:e0196277.
    PubMed     Text format     Abstract available


    January 2017
  78. CHANNANATH AM, Elkum N, Al-Abdulrazzaq D, Tuomilehto J, et al
    Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.
    PLoS One. 2017;12:e0175728.
    PubMed     Text format     Abstract available


  79. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Text format     Abstract available


  80. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Text format     Abstract available


  81. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Text format     Abstract available


  82. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Text format     Abstract available


  83. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Text format     Abstract available


  84. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Text format     Abstract available


  85. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Text format     Abstract available


  86. KRAMER J, Tenberge JG, Kleiter I, Gaissmaier W, et al
    Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    PLoS One. 2017;12:e0174858.
    PubMed     Text format     Abstract available


  87. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Text format     Abstract available


  88. GUSTAFSSON JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, et al
    Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    PLoS One. 2017;12:e0174572.
    PubMed     Text format     Abstract available


  89. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Text format     Abstract available


  90. RAFFEL J, Gafson AR, Dahdaleh S, Malik O, et al
    Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
    PLoS One. 2017;12:e0169546.
    PubMed     Text format     Abstract available


  91. ZITTEMA D, Casteleijn NF, Bakker SJ, Boesten LS, et al
    Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    PLoS One. 2017;12:e0169263.
    PubMed     Text format     Abstract available


  92. KAVALIUNAS A, Manouchehrinia A, Danylaite Karrenbauer V, Gyllensten H, et al
    Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    PLoS One. 2017;12:e0169460.
    PubMed     Text format     Abstract available


  93. ATKILT HS, Turago MG, Tegegne BS
    Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169666.
    PubMed     Text format     Abstract available


  94. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Text format     Abstract available


  95. BONFIGLIO T, Olivero G, Merega E, Di Prisco S, et al
    Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2017;12:e0170825.
    PubMed     Text format     Abstract available


  96. YEUNG KS, Chung BH, Choufani S, Mok MY, et al
    Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    PLoS One. 2017;12:e0169553.
    PubMed     Text format     Abstract available


  97. BYTOFT B, Knorr S, Vlachova Z, Jensen RB, et al
    Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes.
    PLoS One. 2017;12:e0169308.
    PubMed     Text format     Abstract available


  98. URRUTIA I, Martinez R, Lopez-Euba T, Velayos T, et al
    Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.
    PLoS One. 2017;12:e0169389.
    PubMed     Text format     Abstract available


  99. HERNANDEZ-MIR G, McGeachy MJ
    CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.
    PLoS One. 2017;12:e0173655.
    PubMed     Text format     Abstract available


  100. MISTERSKA E, Kaminiarczyk-Pyzalka D, Adamczak K, Adamczyk KA, et al
    Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire.
    PLoS One. 2017;12:e0173768.
    PubMed     Text format     Abstract available


  101. PAPOTTO PH, Marengo EB, Sardinha LR, Carvalho KI, et al
    Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production.
    PLoS One. 2017;12:e0171822.
    PubMed     Text format     Abstract available


  102. KOMEGAE EN, Souza TA, Grund LZ, Lima C, et al
    Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0171796.
    PubMed     Text format     Abstract available


  103. MUNROE ME, Pezant N, Brown MA, Fife DA, et al
    Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.
    PLoS One. 2017;12:e0171193.
    PubMed     Text format     Abstract available


  104. TOFFOLI B, Gilardi F, Winkler C, Soderberg M, et al
    Nephropathy in Pparg-null mice highlights PPARgamma systemic activities in metabolism and in the immune system.
    PLoS One. 2017;12:e0171474.
    PubMed     Text format     Abstract available


  105. ZOU L, Wang H, Xiao Z, Fang Q, et al
    Tai chi for health benefits in patients with multiple sclerosis: A systematic review.
    PLoS One. 2017;12:e0170212.
    PubMed     Text format     Abstract available


  106. NA W, Yi K, Song YS, Park MH, et al
    Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
    PLoS One. 2017;12:e0174501.
    PubMed     Text format     Abstract available


  107. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Text format     Abstract available


  108. LUDVIGSSON J, Jones MP, Faresjo A
    Worm infestations and development of autoimmunity in children - The ABIS study.
    PLoS One. 2017;12:e0173988.
    PubMed     Text format     Abstract available


  109. CECCARELLI F, Sciandrone M, Perricone C, Galvan G, et al
    Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
    PLoS One. 2017;12:e0174200.
    PubMed     Text format     Abstract available


  110. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Text format     Abstract available


  111. FAIZY TD, Thaler C, Ceyrowski T, Broocks G, et al
    Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.
    PLoS One. 2017;12:e0172923.
    PubMed     Text format     Abstract available


  112. MIZUNO M, Noto D, Kaga N, Chiba A, et al
    The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models.
    PLoS One. 2017;12:e0173032.
    PubMed     Text format     Abstract available


  113. BLOSS S, Klemann C, Rother AK, Mehmecke S, et al
    Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.
    PLoS One. 2017;12:e0172532.
    PubMed     Text format     Abstract available


  114. REGNELL SE, Hessner MJ, Jia S, Akesson L, et al
    Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats.
    PLoS One. 2017;12:e0171372.
    PubMed     Text format     Abstract available


  115. MOON Y, McGinnis RS, Seagers K, Motl RW, et al
    Monitoring gait in multiple sclerosis with novel wearable motion sensors.
    PLoS One. 2017;12:e0171346.
    PubMed     Text format     Abstract available


  116. NICHOLAS D, Proctor EA, Raval FM, Ip BC, et al
    Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis.
    PLoS One. 2017;12:e0170975.
    PubMed     Text format     Abstract available


  117. LINK J, Ramanujam R, Auer M, Ryner M, et al
    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
    PLoS One. 2017;12:e0170395.
    PubMed     Text format     Abstract available


  118. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Text format     Abstract available


  119. DILLON MP, Fortington LV, Akram M, Erbas B, et al
    Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12.
    PLoS One. 2017;12:e0170705.
    PubMed     Text format     Abstract available


  120. ETCHEGARAY-MORALES I, Mendez-Martinez S, Jimenez-Hernandez C, Mendoza-Pinto C, et al
    Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.
    PLoS One. 2017;12:e0170209.
    PubMed     Text format     Abstract available


  121. UECKER FC, Olze H, Kunte H, Gerz C, et al
    Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.
    PLoS One. 2017;12:e0170492.
    PubMed     Text format     Abstract available


  122. HURTADO-GUERRERO I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, et al
    Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNss in Multiple Sclerosis Patients According to the Therapeutic Response to IFNss.
    PLoS One. 2017;12:e0170031.
    PubMed     Text format     Abstract available


  123. TIMILSHINA M, Kang Y, Dahal I, You Z, et al
    BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.
    PLoS One. 2017;12:e0168942.
    PubMed     Text format     Abstract available


  124. ELOI M, Horvath DV, Ortega JC, Prado MS, et al
    25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.
    PLoS One. 2017;12:e0170323.
    PubMed     Text format     Abstract available


  125. LIBERTINOVA J, Meluzinova E, Tomek A, Horakova D, et al
    Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNbeta.
    PLoS One. 2017;12:e0169957.
    PubMed     Text format     Abstract available


  126. AZZI J, Thueson L, Moore R, Abdoli R, et al
    PI3Kgamma Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    PLoS One. 2017;12:e0169695.
    PubMed     Text format     Abstract available


  127. FARIA BF, Mostardinha P, Vistulo de Abreu F
    Can the Immune System Perform a t-Test?
    PLoS One. 2017;12:e0169464.
    PubMed     Text format     Abstract available


  128. ESSIEN O, Otu A, Umoh V, Enang O, et al
    Intensive Patient Education Improves Glycaemic Control in Diabetes Compared to Conventional Education: A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital.
    PLoS One. 2017;12:e0168835.
    PubMed     Text format     Abstract available


  129. BROCHET B, Deloire MS, Perez P, Loock T, et al
    Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2017;12:e0168834.
    PubMed     Text format     Abstract available


  130. LAND J, Abdulahad WH, Arends S, Sanders JF, et al
    Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    PLoS One. 2017;12:e0182549.
    PubMed     Text format     Abstract available


  131. VAN ESDONK MJ, Tai B, Cotterill A, Charles B, et al
    Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.
    PLoS One. 2017;12:e0182181.
    PubMed     Text format     Abstract available


  132. WAUGH K, Snell-Bergeon J, Michels A, Dong F, et al
    Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
    PLoS One. 2017;12:e0174840.
    PubMed     Text format     Abstract available


  133. ZHAO Y, Healy BC, Rotstein D, Guttmann CR, et al
    Exploration of machine learning techniques in predicting multiple sclerosis disease course.
    PLoS One. 2017;12:e0174866.
    PubMed     Text format     Abstract available


  134. KIIRE CA, Horak K, Lee KE, Klein BE, et al
    The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study.
    PLoS One. 2017;12:e0174979.
    PubMed     Text format     Abstract available


  135. HEGEN H, Auer M, Bsteh G, Di Pauli F, et al
    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.
    PLoS One. 2017;12:e0174005.
    PubMed     Text format     Abstract available


  136. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Text format     Abstract available


  137. NICKERSON KM, Wang Y, Bastacky S, Shlomchik MJ, et al
    Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
    PLoS One. 2017;12:e0173471.
    PubMed     Text format     Abstract available


  138. LIMA PD, Chen Z, Tayab A, Murphy MS, et al
    Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    PLoS One. 2017;12:e0172988.
    PubMed     Text format     Abstract available


  139. WENDEBOURG MJ, Heesen C, Finlayson M, Meyer B, et al
    Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
    PLoS One. 2017;12:e0173025.
    PubMed     Text format     Abstract available


  140. EUESDEN J, Danese A, Lewis CM, Maughan B, et al
    A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study.
    PLoS One. 2017;12:e0173015.
    PubMed     Text format     Abstract available


  141. ONO N, Murakami K, Chan O, Hall H, et al
    Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes.
    PLoS One. 2017;12:e0173176.
    PubMed     Text format     Abstract available


  142. POURCINE F, Dahan K, Mihout F, Cachanado M, et al
    Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    PLoS One. 2017;12:e0173201.
    PubMed     Text format     Abstract available


  143. MORANDI E, Tanasescu R, Tarlinton RE, Constantinescu CS, et al
    The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172415.
    PubMed     Text format     Abstract available


  144. BEHBEHANI R, Abu Al-Hassan A, Al-Salahat A, Sriraman D, et al
    Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    PLoS One. 2017;12:e0172120.
    PubMed     Text format     Abstract available


  145. VAITAITIS GM, Yussman MG, Waid DM, Wagner DH Jr, et al
    Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    PLoS One. 2017;12:e0172037.
    PubMed     Text format     Abstract available


  146. HISA K, Yanagimachi MD, Naruto T, Miyamae T, et al
    PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    PLoS One. 2017;12:e0171961.
    PubMed     Text format     Abstract available


  147. MOCCIA M, Palladino R, Lanzillo R, Carotenuto A, et al
    Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.
    PLoS One. 2017;12:e0169489.
    PubMed     Text format     Abstract available


  148. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Text format     Abstract available


  149. MAGNUSSON K, Bech Holte K, Juel NG, Brox JI, et al
    Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study.
    PLoS One. 2017;12:e0177118.
    PubMed     Text format     Abstract available


  150. LAM HV, Nguyen DT, Nguyen CD
    Sibling method increases risk assessment estimates for type 1 diabetes.
    PLoS One. 2017;12:e0176341.
    PubMed     Text format     Abstract available


  151. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available


  152. SCOTT A, Chambers D, Goyder E, O'Cathain A, et al
    Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.
    PLoS One. 2017;12:e0177210.
    PubMed     Text format     Abstract available


  153. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Text format     Abstract available


  154. NIEGOWSKA M, Delitala A, Pes GM, Delitala G, et al
    Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.
    PLoS One. 2017;12:e0176584.
    PubMed     Text format     Abstract available


  155. MARINO KR, Lundberg RL, Jasrotia A, Maranda LS, et al
    A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    PLoS One. 2017;12:e0176860.
    PubMed     Text format     Abstract available


  156. IZQUIERDO G, Damas F, Paramo MD, Ruiz-Pena JL, et al
    The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
    PLoS One. 2017;12:e0176174.
    PubMed     Text format     Abstract available


  157. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Text format     Abstract available


  158. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Text format     Abstract available


  159. ZHAN Z, Yang Y, Zhan Y, Chen D, et al
    Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    PLoS One. 2017;12:e0176457.
    PubMed     Text format     Abstract available


  160. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Text format     Abstract available


  161. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Text format     Abstract available


  162. TALMAGE GD, Coppes OJM, Javed A, Bernard J, et al
    Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
    PLoS One. 2017;12:e0173299.
    PubMed     Text format     Abstract available


  163. HARRIS VK, Bell L, Langan RA, Tuddenham J, et al
    Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    PLoS One. 2017;12:e0175575.
    PubMed     Text format     Abstract available


  164. GIESS RM, Pfuhl C, Behrens JR, Rasche L, et al
    Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    PLoS One. 2017;12:e0175279.
    PubMed     Text format     Abstract available


  165. DOBRAKOWSKI P, Bogocz M, Cholewa K, Rajchel M, et al
    Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
    PLoS One. 2017;12:e0175156.
    PubMed     Text format     Abstract available


  166. HANAOKA H, Kiyokawa T, Iida H, Ishimori K, et al
    Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    PLoS One. 2017;12:e0175152.
    PubMed     Text format     Abstract available


  167. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Text format     Abstract available


  168. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Text format     Abstract available


  169. AYUSO T, Aznar P, Soriano L, Olaskoaga A, et al
    Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    PLoS One. 2017;12:e0174726.
    PubMed     Text format     Abstract available


  170. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Text format     Abstract available


  171. MULS N, Nasr Z, Dang HA, Sindic C, et al
    IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
    PLoS One. 2017;12:e0173780.
    PubMed     Text format     Abstract available


  172. HIROOKA K, Saito W, Namba K, Mizuuchi K, et al
    Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    PLoS One. 2017;12:e0172612.
    PubMed     Text format     Abstract available


  173. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Text format     Abstract available


  174. RAGHAV A, Ahmad J, Alam K
    Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    PLoS One. 2017;12:e0176970.
    PubMed     Text format     Abstract available


  175. TAKEUCHI Y, Saito A, Ojima Y, Kagaya S, et al
    The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study.
    PLoS One. 2017;12:e0177482.
    PubMed     Text format     Abstract available


  176. MOLINA-JIJON E, Rodriguez-Munoz R, Gonzalez-Ramirez R, Namorado-Tonix C, et al
    Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    PLoS One. 2017;12:e0177362.
    PubMed     Text format     Abstract available


  177. CHARVET LE, Yang J, Shaw MT, Sherman K, et al
    Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    PLoS One. 2017;12:e0177177.
    PubMed     Text format     Abstract available


  178. BOUGNERES P, Le Fur S, Valtat S, Kamatani Y, et al
    Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.
    PLoS One. 2017;12:e0170658.
    PubMed     Text format     Abstract available


  179. TSAI FJ, Chen SY, Liu YC, Liao HY, et al
    The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice.
    PLoS One. 2017;12:e0181423.
    PubMed     Text format     Abstract available


  180. YUN JS, Bae JM, Kim KJ, Jung YS, et al
    Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
    PLoS One. 2017;12:e0179088.
    PubMed     Text format     Abstract available


  181. PARDO E, Carcamo C, Uribe-San Martin R, Ciampi E, et al
    Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    PLoS One. 2017;12:e0177472.
    PubMed     Text format     Abstract available


  182. LUNDBERG M, Lindqvist A, Wierup N, Krogvold L, et al
    The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.
    PLoS One. 2017;12:e0179911.
    PubMed     Text format     Abstract available


  183. TAUBERT R, Hardtke-Wolenski M, Noyan F, Lalanne C, et al
    Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.
    PLoS One. 2017;12:e0179074.
    PubMed     Text format     Abstract available


  184. PAUZUOLIS M, Eich T, Burman J
    Quantification of gammadelta T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.
    PLoS One. 2017;12:e0179095.
    PubMed     Text format     Abstract available


  185. CHAMI M, Halmer R, Schnoeder L, Anne Becker K, et al
    Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    PLoS One. 2017;12:e0178622.
    PubMed     Text format     Abstract available


  186. GUARDIA-OLMOS J, Gallardo-Moreno GB, Gudayol-Ferre E, Pero-Cebollero M, et al
    Effect of verbal task complexity in a working memory paradigm in patients with type 1 diabetes. A fMRI study.
    PLoS One. 2017;12:e0178172.
    PubMed     Text format     Abstract available


  187. MIYAWAKI Y, Katsuyama T, Sada KE, Hiramatsu S, et al
    A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
    PLoS One. 2017;12:e0178018.
    PubMed     Text format     Abstract available


  188. PARK JY, Yang HK, Hwang JM
    Diagnostic value of repeated ice tests in the evaluation of ptosis in myasthenia gravis.
    PLoS One. 2017;12:e0177078.
    PubMed     Text format     Abstract available


  189. LU G, Zhang X, Shen L, Qiao Q, et al
    CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy.
    PLoS One. 2017;12:e0178352.
    PubMed     Text format     Abstract available


  190. GUO R, Zhou Y, Lu L, Cao L, et al
    Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease.
    PLoS One. 2017;12:e0177774.
    PubMed     Text format     Abstract available


  191. SEOK JM, Choi M, Cho EB, Lee HL, et al
    Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.
    PLoS One. 2017;12:e0177230.
    PubMed     Text format     Abstract available


  192. NISHIKAI-YAN SHEN T, Kanazawa S, Kado M, Okada K, et al
    Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice.
    PLoS One. 2017;12:e0178232.
    PubMed     Text format     Abstract available


  193. MOLLISON D, Sellar R, Bastin M, Mollison D, et al
    The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177727.
    PubMed     Text format     Abstract available


  194. ALSOP J, Medin J, Cornelissen C, Vormfelde SV, et al
    Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.
    PLoS One. 2017;12:e0173353.
    PubMed     Text format     Abstract available


  195. TONGYOO P, Avihingsanon Y, Prom-On S, Mutirangura A, et al
    EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes.
    PLoS One. 2017;12:e0177119.
    PubMed     Text format     Abstract available


  196. IP FCF, Ng YP, Or TCT, Sun P, et al
    Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.
    PLoS One. 2017;12:e0182069.
    PubMed     Text format     Abstract available


  197. BSTEH G, Ehling R, Walchhofer LM, Hegen H, et al
    Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.
    PLoS One. 2017;12:e0181458.
    PubMed     Text format     Abstract available


  198. GARCIA TS, Rech TH, Leitao CB
    Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.
    PLoS One. 2017;12:e0180911.
    PubMed     Text format     Abstract available


  199. BERNITSAS E, Khan O, Razmjou S, Tselis A, et al
    Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.
    PLoS One. 2017;12:e0181431.
    PubMed     Text format     Abstract available


  200. TORTOSA C, Cabrera-Marante O, Serrano M, Martinez-Flores JA, et al
    Incidence of thromboembolic events in asymptomatic carriers of IgA anti ss2 glycoprotein-I antibodies.
    PLoS One. 2017;12:e0178889.
    PubMed     Text format     Abstract available


  201. LEISS H, Salzberger W, Jacobs B, Gessl I, et al
    MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.
    PLoS One. 2017;12:e0181015.
    PubMed     Text format     Abstract available


  202. DIESTELHORST J, Junge N, Schlue J, Falk CS, et al
    Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    PLoS One. 2017;12:e0181107.
    PubMed     Text format     Abstract available


  203. REIMER A, Schmitt A, Ehrmann D, Kulzer B, et al
    Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study.
    PLoS One. 2017;12:e0181218.
    PubMed     Text format     Abstract available


  204. HAUPT-JORGENSEN M, Nielsen E, Engkilde K, Lerche M, et al
    Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study.
    PLoS One. 2017;12:e0181143.
    PubMed     Text format     Abstract available


  205. WHEELOCK KM, Cai J, Looker HC, Merchant ML, et al
    Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    PLoS One. 2017;12:e0180964.
    PubMed     Text format     Abstract available


  206. SILVA SL, Albuquerque A, Amaral AJ, Li QZ, et al
    Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy.
    PLoS One. 2017;12:e0180385.
    PubMed     Text format     Abstract available


  207. RIGHART R, Schmidt P, Dahnke R, Biberacher V, et al
    Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients.
    PLoS One. 2017;12:e0179590.
    PubMed     Text format     Abstract available


  208. TAKAHASHI H, Nishimura R, Onda Y, Ando K, et al
    Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.
    PLoS One. 2017;12:e0177283.
    PubMed     Text format     Abstract available


  209. TOVOTE KA, Schroevers MJ, Snippe E, Emmelkamp PMG, et al
    What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes.
    PLoS One. 2017;12:e0179941.
    PubMed     Text format     Abstract available


  210. ROBERTS FR, Hupple C, Norowski E, Walsh NC, et al
    Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model.
    PLoS One. 2017;12:e0178641.
    PubMed     Text format     Abstract available


  211. SATO K, Nishijima T, Yokokawa T, Fujita S, et al
    Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes.
    PLoS One. 2017;12:e0178505.
    PubMed     Text format     Abstract available


  212. MCGINNIS RS, Mahadevan N, Moon Y, Seagers K, et al
    A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.
    PLoS One. 2017;12:e0178366.
    PubMed     Text format     Abstract available


  213. NYALWIDHE JO, Grzesik WJ, Burch TC, Semeraro ML, et al
    Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetes.
    PLoS One. 2017;12:e0183908.
    PubMed     Text format     Abstract available


  214. GRANADOS HM, Draghi A 2nd, Tsurutani N, Wright K, et al
    Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes.
    PLoS One. 2017;12:e0183887.
    PubMed     Text format     Abstract available


  215. THALER C, Schneider T, Sedlacik J, Kutzner D, et al
    T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.
    PLoS One. 2017;12:e0183099.
    PubMed     Text format     Abstract available


  216. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
    PLoS One. 2017;12:e0182479.
    PubMed     Text format     Abstract available


  217. TAKAYASU L, Suda W, Watanabe E, Fukuda S, et al
    A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes.
    PLoS One. 2017;12:e0180863.
    PubMed     Text format     Abstract available


  218. VILLANI M, Nanayakkara N, Ranasinha S, Earnest A, et al
    Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study.
    PLoS One. 2017;12:e0182413.
    PubMed     Text format     Abstract available


  219. DE RIVA A, Wallberg M, Ronchi F, Coulson R, et al
    Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.
    PLoS One. 2017;12:e0181964.
    PubMed     Text format     Abstract available


  220. MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
    PLoS One. 2017;12:e0181564.
    PubMed     Text format     Abstract available


  221. LEE KY, Yoo BW, Ahn SS, Bae WH, et al
    Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
    PLoS One. 2017;12:e0181590.
    PubMed     Text format     Abstract available


  222. LANDI D, Albanese M, Buttari F, Monteleone F, et al
    Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.
    PLoS One. 2017;12:e0165415.
    PubMed     Text format     Abstract available


  223. REVEIZ L, Haby MM, Martinez-Vega R, Pinzon-Flores CE, et al
    Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols.
    PLoS One. 2017;12:e0180220.
    PubMed     Text format     Abstract available


  224. NEGI S, Singh H, Mukhopadhyay A
    Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study.
    PLoS One. 2017;12:e0180518.
    PubMed     Text format     Abstract available


  225. CHANG YW, Chou YC, Yeh CC, Hu CJ, et al
    Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study.
    PLoS One. 2017;12:e0180433.
    PubMed     Text format     Abstract available


  226. JONAS SF, Mbogning C, Hassler S, Broet P, et al
    A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.
    PLoS One. 2017;12:e0179896.
    PubMed     Text format     Abstract available


  227. CHARALAMPOPOULOS D, Hesketh KR, Amin R, Paes VM, et al
    Psycho-educational interventions for children and young people with Type 1 Diabetes in the UK: How effective are they? A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179685.
    PubMed     Text format     Abstract available


  228. TANG KT, Hsieh TY, Chao YH, Lin MX, et al
    Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
    PLoS One. 2017;12:e0178404.
    PubMed     Text format     Abstract available


  229. EBBO M, Grados A, Samson M, Groh M, et al
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    PLoS One. 2017;12:e0183844.
    PubMed     Text format     Abstract available


  230. REN S, Wang Y, Xian L, Toyama T, et al
    Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    PLoS One. 2017;12:e0184398.
    PubMed     Text format     Abstract available


  231. WURTH S, Kuenz B, Bsteh G, Ehling R, et al
    Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    PLoS One. 2017;12:e0182462.
    PubMed     Text format     Abstract available


  232. LIN TS, Hsu PY, Chang CH, Ko CL, et al
    Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
    PLoS One. 2017;12:e0182344.
    PubMed     Text format     Abstract available


  233. MESSINA S, Solaro C, Righini I, Bergamaschi R, et al
    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
    PLoS One. 2017;12:e0180651.
    PubMed     Text format     Abstract available


  234. KARAMPETSOU MP, Comte D, Kis-Toth K, Kyttaris VC, et al
    Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
    PLoS One. 2017;12:e0186073.
    PubMed     Text format     Abstract available


  235. MARITATI F, Alberici F, Oliva E, Urban ML, et al
    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    PLoS One. 2017;12:e0185880.
    PubMed     Text format     Abstract available


  236. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Text format     Abstract available


  237. KISO K, Yoshifuji H, Oku T, Hikida M, et al
    Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.
    PLoS One. 2017;12:e0184738.
    PubMed     Text format     Abstract available


  238. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Text format     Abstract available


  239. DIAZ-RIZO V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, et al
    Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
    PLoS One. 2017;12:e0184056.
    PubMed     Text format     Abstract available


  240. NEEDELL JC, Ir D, Robertson CE, Kroehl ME, et al
    Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.
    PLoS One. 2017;12:e0183786.
    PubMed     Text format     Abstract available


  241. MAULUCCI G, Cordelli E, Rizzi A, De Leva F, et al
    Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    PLoS One. 2017;12:e0184109.
    PubMed     Text format     Abstract available


  242. MANUWALD U, Heinke P, Salzsieder E, Hegewald J, et al
    Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany.
    PLoS One. 2017;12:e0183665.
    PubMed     Text format     Abstract available


  243. PUTHENPARAMPIL M, Federle L, Poggiali D, Miante S, et al
    Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    PLoS One. 2017;12:e0183957.
    PubMed     Text format     Abstract available


  244. BLAZER A, Wang B, Simpson D, Kirchhoff T, et al
    Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
    PLoS One. 2017;12:e0182483.
    PubMed     Text format     Abstract available


  245. CEUNINCK VAN CAPELLE A, Meide HV, Vosman FJH, Visser LH, et al
    A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS).
    PLoS One. 2017;12:e0182806.
    PubMed     Text format     Abstract available


  246. ABDELHAK A, Hottenrott T, Mayer C, Hintereder G, et al
    CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    PLoS One. 2017;12:e0182647.
    PubMed     Text format     Abstract available


  247. MODICA CM, Schweser F, Sudyn ML, Bertolino N, et al
    Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0182729.
    PubMed     Text format     Abstract available


  248. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Text format     Abstract available


  249. SONG F, Qian Y, Peng X, Li X, et al
    The frontline of immune response in peripheral blood.
    PLoS One. 2017;12:e0182294.
    PubMed     Text format     Abstract available


  250. WASHBURN N, Meccariello R, Hu S, Hains M, et al
    High-resolution physicochemical characterization of different intravenous immunoglobulin products.
    PLoS One. 2017;12:e0181251.
    PubMed     Text format     Abstract available


  251. SILVA-VILCHES C, Pletinckx K, Lohnert M, Pavlovic V, et al
    Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.
    PLoS One. 2017;12:e0178114.
    PubMed     Text format     Abstract available


  252. KIDD T, Carey N, Mold F, Westwood S, et al
    A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life.
    PLoS One. 2017;12:e0185931.
    PubMed     Text format     Abstract available


  253. HU WS, Rajendran P, Tzang BS, Yeh YL, et al
    Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.
    PLoS One. 2017;12:e0185098.
    PubMed     Text format     Abstract available


  254. KIM HH, Jeong IH, Hyun JS, Kong BS, et al
    Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    PLoS One. 2017;12:e0181758.
    PubMed     Text format     Abstract available


  255. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Text format     Abstract available


  256. FAVARETTO A, Lazzarotto A, Riccardi A, Pravato S, et al
    Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis.
    PLoS One. 2017;12:e0185626.
    PubMed     Text format     Abstract available


  257. MAKINO T, Nakamura R, Terakawa M, Muneoka S, et al
    Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
    PLoS One. 2017;12:e0185976.
    PubMed     Text format     Abstract available


  258. LUO W, Zhou B, Luo Q, Fang H, et al
    Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population.
    PLoS One. 2017;12:e0186409.
    PubMed     Text format     Abstract available


  259. PERROTTI PP, Aterido A, Fernandez-Nebro A, Canete JD, et al
    Genetic variation associated with cardiovascular risk in autoimmune diseases.
    PLoS One. 2017;12:e0185889.
    PubMed     Text format     Abstract available


  260. MIETTINEN ME, Smart MC, Kinnunen L, Harjutsalo V, et al
    Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.
    PLoS One. 2017;12:e0184942.
    PubMed     Text format     Abstract available


  261. KURIAN SM, Ferreri K, Wang CH, Todorov I, et al
    Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice.
    PLoS One. 2017;12:e0185331.
    PubMed     Text format     Abstract available


  262. LIN JD, Yang SF, Wang YH, Fang WF, et al
    Associations of melatonin receptor gene polymorphisms with Graves' disease.
    PLoS One. 2017;12:e0185529.
    PubMed     Text format     Abstract available


  263. BERGGREN O, Hagberg N, Alexsson A, Weber G, et al
    Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
    PLoS One. 2017;12:e0183946.
    PubMed     Text format     Abstract available


  264. MASUDA H, Hirano S, Takahashi N, Hatsugano E, et al
    Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
    PLoS One. 2017;12:e0184012.
    PubMed     Text format     Abstract available


  265. RAIMONDO MG, Pericleous C, Radziszewska A, Borghi MO, et al
    Oxidation of beta2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
    PLoS One. 2017;12:e0186513.
    PubMed     Text format     Abstract available


  266. FERNANDEZ O, Duran E, Ayuso T, Hernandez L, et al
    Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).
    PLoS One. 2017;12:e0185766.
    PubMed     Text format     Abstract available


  267. ASANO T, Ito H, Kariya Y, Hoshi K, et al
    Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    PLoS One. 2017;12:e0186414.
    PubMed     Text format     Abstract available


  268. POPPERUD TH, Viken MK, Kerty E, Lie BA, et al
    Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    PLoS One. 2017;12:e0186383.
    PubMed     Text format     Abstract available


  269. BESELER C, Vollmer T, Graner M, Yu X, et al
    The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    PLoS One. 2017;12:e0186842.
    PubMed     Text format     Abstract available


  270. GUSTAFSSON P, Crenshaw AG, Edmundsson D, Toolanen G, et al
    Muscle oxygenation in Type 1 diabetic and non-diabetic patients with and without chronic compartment syndrome.
    PLoS One. 2017;12:e0186790.
    PubMed     Text format     Abstract available


  271. WU YD, Lin CH, Chao WC, Liao TL, et al
    Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0187075.
    PubMed     Text format     Abstract available


  272. GOLEBIEWSKA J, Olechowski A, Wysocka-Mincewicz M, Odrobina D, et al
    Optical coherence tomography angiography vessel density in children with type 1 diabetes.
    PLoS One. 2017;12:e0186479.
    PubMed     Text format     Abstract available


  273. KENDRICK SK, Zheng Q, Garbett NC, Brock GN, et al
    Application and interpretation of functional data analysis techniques to differential scanning calorimetry data from lupus patients.
    PLoS One. 2017;12:e0186232.
    PubMed     Text format     Abstract available


  274. AL HARIRI M, Elmedawar M, Zhu R, Jaffa MA, et al
    Proteome profiling in the aorta and kidney of type 1 diabetic rats.
    PLoS One. 2017;12:e0187752.
    PubMed     Text format     Abstract available


  275. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.
    PLoS One. 2017;12:e0187645.
    PubMed     Text format     Abstract available


  276. CONTRERAS I, Oviedo S, Vettoretti M, Visentin R, et al
    Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models.
    PLoS One. 2017;12:e0187754.
    PubMed     Text format     Abstract available


  277. HONORAT JA, Nakatsuji Y, Shimizu M, Kinoshita M, et al
    Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner.
    PLoS One. 2017;12:e0187215.
    PubMed     Text format     Abstract available


  278. RAKNES G, Smabrekke L
    Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.
    PLoS One. 2017;12:e0187423.
    PubMed     Text format     Abstract available


  279. INAGAKI K, Yasuda Y, Ando M, Kaihan AB, et al
    Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.
    PLoS One. 2017;12:e0187607.
    PubMed     Text format     Abstract available


  280. OKA S, Furukawa H, Yasunami M, Kawasaki A, et al
    HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
    PLoS One. 2017;12:e0187325.
    PubMed     Text format     Abstract available


  281. ESTEVE C, Samson M, Guilhem A, Nicolas B, et al
    Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    PLoS One. 2017;12:e0187296.
    PubMed     Text format     Abstract available


  282. HOUSHMAND-OEREGAARD A, Hjort L, Kelstrup L, Hansen NS, et al
    DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy.
    PLoS One. 2017;12:e0187038.
    PubMed     Text format     Abstract available


  283. LIN SJ, Kuo ML, Hsiao HS, Lee PT, et al
    Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.
    PLoS One. 2017;12:e0186223.
    PubMed     Text format     Abstract available


  284. CHOI JY, Jung JH, Shin S, Kim YH, et al
    Association between the pancreas transplantation and survival of patients with diabetes: A single center experience.
    PLoS One. 2017;12:e0186827.
    PubMed     Text format     Abstract available


  285. AL-RUBEAAN K, Almashouq MK, Youssef AM, Al-Qumaidi H, et al
    All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia.
    PLoS One. 2017;12:e0188097.
    PubMed     Text format     Abstract available


  286. MOISSET X, Perie M, Pereira B, Dumont E, et al
    Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study.
    PLoS One. 2017;12:e0188120.
    PubMed     Text format     Abstract available


  287. MIYAZAWA M, Takatori H, Shimakami T, Kawaguchi K, et al
    Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    PLoS One. 2017;12:e0188549.
    PubMed     Text format     Abstract available


  288. NAVARRO-QUIROZ E, Pacheco-Lugo L, Navarro-Quiroz R, Lorenzi H, et al
    Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
    PLoS One. 2017;12:e0187973.
    PubMed     Text format     Abstract available


  289. DUNHAM J, van de Vis R, Bauer J, Wubben J, et al
    Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey.
    PLoS One. 2017;12:e0188013.
    PubMed     Text format     Abstract available


  290. WEN J, Yablonskiy DA, Salter A, Cross AH, et al
    Limbic system damage in MS: MRI assessment and correlations with clinical testing.
    PLoS One. 2017;12:e0187915.
    PubMed     Text format     Abstract available


  291. LADFORS L, Shaat N, Wiberg N, Katasarou A, et al
    Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.
    PLoS One. 2017;12:e0187917.
    PubMed     Text format     Abstract available


  292. KORF H, Breser L, Van Hoeck J, Godoy J, et al
    MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.
    PLoS One. 2017;12:e0187455.
    PubMed     Text format     Abstract available


  293. DE GROOT PF, Belzer C, Aydin O, Levin E, et al
    Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study.
    PLoS One. 2017;12:e0188475.
    PubMed     Text format     Abstract available


  294. JONES IV AR, Coleman EL, Husni NR, Deeney JT, et al
    Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.
    PLoS One. 2017;12:e0188474.
    PubMed     Text format     Abstract available


  295. TANG X, Zhao S, Chiu APY, Wang X, et al
    Analysing increasing trends of Guillain-Barre Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.
    PLoS One. 2017;12:e0187830.
    PubMed     Text format     Abstract available


  296. HORVEI KD, Pedersen HL, Fismen S, Thiyagarajan D, et al
    Lupus nephritis progression in FcgammaRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.
    PLoS One. 2017;12:e0188863.
    PubMed     Text format     Abstract available


  297. PARKKOLA A, Laine AP, Karhunen M, Harkonen T, et al
    HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes.
    PLoS One. 2017;12:e0188402.
    PubMed     Text format     Abstract available


  298. LIU S, Liu X, Chen S, Xiao Y, et al
    Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0188644.
    PubMed     Text format     Abstract available


  299. YU MY, Kim YC, Koo HS, Chin HJ, et al
    Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    PLoS One. 2017;12:e0188375.
    PubMed     Text format     Abstract available


  300. DOUBLIER S, Zennaro C, Musante L, Spatola T, et al
    Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    PLoS One. 2017;12:e0188045.
    PubMed     Text format     Abstract available


  301. GARBETT NC, Brock GN, Chaires JB, Mekmaysy CS, et al
    Characterization and classification of lupus patients based on plasma thermograms.
    PLoS One. 2017;12:e0186398.
    PubMed     Text format     Abstract available


  302. WYBRECHT D, Reuter F, Pariollaud F, Zaaraoui W, et al
    New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
    PLoS One. 2017;12:e0184650.
    PubMed     Text format     Abstract available


  303. IRACE C, Messiniti V, Tassone B, Cortese C, et al
    Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes.
    PLoS One. 2017;12:e0187525.
    PubMed     Text format     Abstract available


  304. GROBELNY A, Behrens JR, Mertens S, Otte K, et al
    Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    PLoS One. 2017;12:e0189281.
    PubMed     Text format     Abstract available


  305. PERRI V, Gianchecchi E, Cifaldi L, Pellegrino M, et al
    Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.
    PLoS One. 2017;12:e0189615.
    PubMed     Text format     Abstract available


  306. GREENFIELD J, Hudson M, Vinet E, Fortin PR, et al
    A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
    PLoS One. 2017;12:e0189840.
    PubMed     Text format     Abstract available


  307. CHEN Y, Zhen W, Guo T, Zhao Y, et al
    Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    PLoS One. 2017;12:e0189380.
    PubMed     Text format     Abstract available


  308. SASIDHAR MV, Chevooru SK, Eickelberg O, Hartung HP, et al
    Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    PLoS One. 2017;12:e0189701.
    PubMed     Text format     Abstract available


    January 2016
  309. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Text format     Abstract available


  310. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Text format     Abstract available


  311. MAGGI L, Margheri F, Luciani C, Capone M, et al
    Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.
    PLoS One. 2016;11:e0154422.
    PubMed     Text format     Abstract available


  312. RAMONDT S, Tiemensma J, Cameron LD, Broadbent E, et al
    Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study.
    PLoS One. 2016;11:e0154348.
    PubMed     Text format     Abstract available


  313. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Text format     Abstract available


  314. HAASNOOT AJ, Vernie LA, Rothova A, V D Doe P, et al
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016;11:e0164312.
    PubMed     Text format     Abstract available


  315. KAUSHIK DK, Yong HY, Hahn JN, Silva C, et al
    Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    PLoS One. 2016;11:e0163802.
    PubMed     Text format     Abstract available


  316. KALRON A, Givon U, Frid L, Dolev M, et al
    Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
    PLoS One. 2016;11:e0164467.
    PubMed     Text format     Abstract available


  317. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Text format     Abstract available


  318. RIEMANN-LORENZ K, Eilers M, von Geldern G, Schulz KH, et al
    Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
    PLoS One. 2016;11:e0165246.
    PubMed     Text format     Abstract available


  319. MANICARDI V, Russo G, Napoli A, Torlone E, et al
    Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016;11:e0162960.
    PubMed     Text format     Abstract available


  320. JERNAS L, Wencel J, Wiak A, Bieniek M, et al
    Risk Factors for Poor Adherence to Betaferon(R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.
    PLoS One. 2016;11:e0157950.
    PubMed     Text format     Abstract available


  321. OKANO J, Kojima H, Katagi M, Nakagawa T, et al
    Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.
    PLoS One. 2016;11:e0166215.
    PubMed     Text format     Abstract available


  322. DOBSON R, Ramagopalan S, Topping J, Smith P, et al
    A Risk Score for Predicting Multiple Sclerosis.
    PLoS One. 2016;11:e0164992.
    PubMed     Text format     Abstract available


  323. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Text format     Abstract available


  324. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Text format     Abstract available


  325. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Text format     Abstract available


  326. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Text format     Abstract available


  327. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Text format     Abstract available


  328. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available


  329. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Text format     Abstract available


  330. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Text format     Abstract available


  331. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Text format     Abstract available


  332. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Text format     Abstract available


  333. WANG X, Liu W, O'Donnell M, Lutgendorf S, et al
    Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    PLoS One. 2016;11:e0168772.
    PubMed     Text format     Abstract available


  334. PIVOT D, Debouverie M, Grzebyk M, Brassat D, et al
    Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    PLoS One. 2016;11:e0167556.
    PubMed     Text format     Abstract available


  335. MURIS AH, Smolders J, Rolf L, Klinkenberg LJ, et al
    Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    PLoS One. 2016;11:e0156122.
    PubMed     Text format     Abstract available


  336. STAMILE C, Kocevar G, Cotton F, Durand-Dubief F, et al
    A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
    PLoS One. 2016;11:e0156405.
    PubMed     Text format     Abstract available


  337. DORONIN VB, Parkhomenko TA, Castellazzi M, Cesnik E, et al
    Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0154688.
    PubMed     Text format     Abstract available


  338. YASUI J, Kawasaki E, Tanaka S, Awata T, et al
    Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    PLoS One. 2016;11:e0155643.
    PubMed     Text format     Abstract available


  339. CHEN HH, Lin IC, Chen HJ, Yeh SY, et al
    Association of Herpes Zoster and Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0155175.
    PubMed     Text format     Abstract available


  340. LAIBLE M, Jarius S, Mackensen F, Schmidt-Bacher A, et al
    Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0155322.
    PubMed     Text format     Abstract available


  341. BEGGS CB, Magnano C, Belov P, Krawiecki J, et al
    Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0153960.
    PubMed     Text format     Abstract available


  342. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Text format     Abstract available


  343. LAMPRIANOU S, Gysemans C, Bou Saab J, Pontes H, et al
    Glibenclamide Prevents Diabetes in NOD Mice.
    PLoS One. 2016;11:e0168839.
    PubMed     Text format     Abstract available


  344. SALEHI Z, Doosti R, Beheshti M, Janzamin E, et al
    Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    PLoS One. 2016;11:e0159565.
    PubMed     Text format     Abstract available


  345. BSTEH G, Ehling R, Lutterotti A, Hegen H, et al
    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
    PLoS One. 2016;11:e0158978.
    PubMed     Text format     Abstract available


  346. VIROSTKO J, Hilmes M, Eitel K, Moore DJ, et al
    Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    PLoS One. 2016;11:e0158825.
    PubMed     Text format     Abstract available


  347. LUIPPOLD G, Bedenik J, Voigt A, Grempler R, et al
    Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    PLoS One. 2016;11:e0156346.
    PubMed     Text format     Abstract available


  348. KARAMYAN A, Dunser MW, Wiebe DJ, Pilz G, et al
    Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
    PLoS One. 2016;11:e0155795.
    PubMed     Text format     Abstract available


  349. JELINEK GA, De Livera AM, Marck CH, Brown CR, et al
    Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
    PLoS One. 2016;11:e0161701.
    PubMed     Text format     Abstract available


  350. BINZ N, Rakoczy EP, Ali Rahman IS, Vagaja NN, et al
    Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
    PLoS One. 2016;11:e0160442.
    PubMed     Text format     Abstract available


  351. ABURAWI EH, AlKaabi J, Zoubeidi T, Shehab A, et al
    Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    PLoS One. 2016;11:e0159808.
    PubMed     Text format     Abstract available


  352. DARABIAN S, Backlund JY, Cleary PA, Sheidaee N, et al
    Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study.
    PLoS One. 2016;11:e0159958.
    PubMed     Text format     Abstract available


  353. DAVIES JL, Thompson S, Kaur-Sandhu H, Sawcer S, et al
    Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
    PLoS One. 2016;11:e0158327.
    PubMed     Text format     Abstract available


  354. DENNISON L, McCloy Smith E, Bradbury K, Galea I, et al
    How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
    PLoS One. 2016;11:e0158982.
    PubMed     Text format     Abstract available


  355. DAHL LC, Nasa Z, Chung J, Niego B, et al
    The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
    PLoS One. 2016;11:e0158653.
    PubMed     Text format     Abstract available


  356. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Text format     Abstract available


  357. VALLERIE SN, Kramer F, Barnhart S, Kanter JE, et al
    Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.
    PLoS One. 2016;11:e0158316.
    PubMed     Text format     Abstract available


  358. SATUE M, Rodrigo MJ, Otin S, Bambo MP, et al
    Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0157293.
    PubMed     Text format     Abstract available


  359. QIN W, Liang YZ, Qin BY, Zhang JL, et al
    The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
    PLoS One. 2016;11:e0156959.
    PubMed     Text format     Abstract available


  360. D'AMICO E, Leone C, Graziano G, Amato MP, et al
    The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
    PLoS One. 2016;11:e0157721.
    PubMed     Text format     Abstract available


  361. BOUDARHAM J, Hameau S, Zory R, Hardy A, et al
    Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0158267.
    PubMed     Text format     Abstract available


  362. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Text format     Abstract available


  363. RIQUELME MEDINA I, Lubovac-Pilav Z
    Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.
    PLoS One. 2016;11:e0156006.
    PubMed     Text format     Abstract available


  364. BUERTH C, Mausberg AK, Heininger MK, Hartung HP, et al
    Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    PLoS One. 2016;11:e0155082.
    PubMed     Text format     Abstract available


  365. MASSA MG, Gisevius B, Hirschberg S, Hinz L, et al
    Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0155274.
    PubMed     Text format     Abstract available


  366. MCEWAN P, Bennett H, Fellows J, Priaulx J, et al
    The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162441.
    PubMed     Text format     Abstract available


  367. SOLARO C, Trabucco E, Signori A, Martinelli V, et al
    Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
    PLoS One. 2016;11:e0160261.
    PubMed     Text format     Abstract available


  368. SAVASTIO S, Cadario F, Genoni G, Bellomo G, et al
    Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162554.
    PubMed     Text format     Abstract available


  369. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Text format     Abstract available


  370. BOHN B, Karges B, Vogel C, Otto KP, et al
    20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
    PLoS One. 2016;11:e0160971.
    PubMed     Text format     Abstract available


  371. FERNANDEZ O, Arroyo R, Martinez-Yelamos S, Marco M, et al
    Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart(R) Device in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0160313.
    PubMed     Text format     Abstract available


  372. GRACIEN RM, Jurcoane A, Wagner M, Reitz SC, et al
    The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0161036.
    PubMed     Text format     Abstract available


  373. HASEDA F, Imagawa A, Nishikawa H, Mitsui S, et al
    Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes.
    PLoS One. 2016;11:e0160576.
    PubMed     Text format     Abstract available


  374. IANNETTA M, Zingaropoli MA, Bellizzi A, Morreale M, et al
    Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    PLoS One. 2016;11:e0160277.
    PubMed     Text format     Abstract available


  375. GILLI F, Chen X, Pachner AR, Gimi B, et al
    High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0160071.
    PubMed     Text format     Abstract available


  376. MARTIN JE, Raffel J, Nicholas R
    Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
    PLoS One. 2016;11:e0159210.
    PubMed     Text format     Abstract available


  377. DASKALAKI E, Diem P, Mougiakakou SG
    Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.
    PLoS One. 2016;11:e0158722.
    PubMed     Text format     Abstract available


  378. ERNSTSSON O, Gyllensten H, Alexanderson K, Tinghog P, et al
    Cost of Illness of Multiple Sclerosis - A Systematic Review.
    PLoS One. 2016;11:e0159129.
    PubMed     Text format     Abstract available


  379. AKAMATSU M, Makino N, Ikeda Y, Matsuda A, et al
    Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    PLoS One. 2016;11:e0158669.
    PubMed     Text format     Abstract available


  380. OBERT D, Helms G, Sattler MB, Jung K, et al
    Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    PLoS One. 2016;11:e0162583.
    PubMed     Text format     Abstract available


  381. CLAUSEN TD, Bergholt T, Bouaziz O, Arpi M, et al
    Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.
    PLoS One. 2016;11:e0161654.
    PubMed     Text format     Abstract available


  382. FATIMA N, Faisal SM, Zubair S, Ajmal M, et al
    Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects.
    PLoS One. 2016;11:e0161548.
    PubMed     Text format     Abstract available


  383. MURAKAMI T, Uji A, Suzuma K, Dodo Y, et al
    In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography.
    PLoS One. 2016;11:e0160317.
    PubMed     Text format     Abstract available


  384. PAOLICELLI D, Iannazzo S, Santoni L, Iaffaldano A, et al
    The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
    PLoS One. 2016;11:e0159214.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: